• Re: U.S. monkeypox response mirrors early Biden coronavirus missteps, e

    From Monkeypox Pride Month@21:1/5 to All on Wed Aug 3 02:00:53 2022
    XPost: talk.politics.guns, alt.politics.homosexuality, alt.politics.nationalism.black
    XPost: alt.hollywood

    In article <t2h8uj$3ke3j$[email protected]>
    <[email protected]> wrote:

    Public health experts, including within the Biden
    administration, are increasingly concerned that the federal
    government�s handling of the largest-ever U.S. monkeypox
    outbreak is mirroring its cumbersome response to the coronavirus
    pandemic 2� years ago, with potentially dire consequences.

    As a result, they said, community transmission is occurring
    largely undetected, and the critical window in which to control
    the outbreak is closing quickly.

    �It�s been unbelievably challenging,� said Lauren Sauer,
    director of the Special Pathogens Research Network within a
    government-funded consortium of medical centers focused on
    pathogens training and education. �It felt like January 2020 all
    over again.�

    More than 150 monkeypox cases have been identified in the United
    States since May 19, federal officials said this week, and more
    than 3,300 cases have been detected in 42 countries around the
    world.

    The rapidly rising global case counts have prompted the World
    Health Organization to convene an emergency committee on
    Thursday to assess whether the monkeypox outbreak represents a
    public health emergency of international concern � the agency�s
    highest-level warning, which currently applies only to the
    coronavirus and polio.

    But as other nations have ramped up their efforts to track and
    prevent the spread of infection, experts say the United States
    has moved too slowly to expand access to monkeypox testing and
    vaccinate people at highest risk. The government�s failure to
    clearly and urgently communicate the symptoms and risks
    associated with monkeypox, a disease spread by close contact
    that can lead to fever, pain and a visible rash, has left gay
    and bisexual men who are disproportionately contracting the
    virus especially vulnerable, public health experts say.

    The plodding U.S. response so far raises doubts about the
    country�s preparedness for the next pandemic, some
    administration officials say.

    Communication about whom to test, when to test them and what
    monkeypox symptoms look like has been dismal, said Sauer, a
    public health expert at the University of Nebraska Medical
    Center.

    Frustrations are running particularly high because, unlike the
    coronavirus, monkeypox has been studied for decades by global
    and U.S. experts who know the tools, strategies and vaccine
    protocols that can limit spread.

    Biden administration officials on Wednesday said that they have
    amply prepared for a monkeypox outbreak, touting the
    government�s efforts to acquire more vaccine doses, warn the
    public about the emerging outbreak, and begin distributing tests
    to commercial labs across the country this week. They also
    insisted their response reflected lessons learned from fighting
    coronavirus, such as waiting to distribute the �right test that
    works� to laboratories after federal officials distributed
    flawed coronavirus tests in early 2020.

    �All this work takes weeks to get it done right,� said Raj
    Panjabi, who leads the White House�s global health security
    efforts, reflecting on the �humility� that he said officials
    have tried to apply to monkeypox after struggles in containing
    the coronavirus and other outbreaks.

    Monkeypox dilemma: How to warn gay men about risk without
    fueling hate

    Clinicians, patients and some administration officials have
    faulted the Centers for Disease Control and Prevention for
    testing criteria that they say are too narrow and have resulted
    in long waits � sometimes multiple days � in identifying
    positive cases. Under the current framework, physicians who want
    a test for an individual suspected to have monkeypox must first
    consult with a state epidemiologist. State public health
    officials say that protocol helps identify people at highest
    risk so doctors can recommend isolation and take other steps to
    prevent community spread.

    And just as in early 2020, when the coronavirus first menaced
    the United States, federal officials at first limited monkeypox
    testing to a network of several dozen public health laboratories
    � and did not authorize thousands of commercial laboratories and
    hospitals to perform their own testing, too.

    Monkeypox testing is handled by 86 mostly state and local public
    health labs, with capacity for more than 8,000 tests a week,
    according to the CDC. But an official of a large city health
    department who is working directly on monkeypox response said
    that number is misleading, because the labs are not concentrated
    around the major metropolitan areas where the bulk of infections
    are detected.

    Without better access to tests, which involves swabbing a
    lesion, it is impossible for public health officials to know the
    true prevalence of the disease.

    Monkeypox has repeatedly emerged in Central and West Africa for
    decades, but the current outbreak has been occurring in
    countries that have not previously reported infections, raising
    concern about how and why the disease appears to be gaining a
    foothold in countries including Britain, Germany, Portugal and
    Spain.

    The response has also been hindered by U.S. physicians� lack of
    familiarity with the rare disease. The CDC initially publicized
    decades-old photos from more severe outbreaks in Africa, instead
    of the more subtle rashes detected in the recent global
    outbreak. The United States was far slower than Britain and
    Canada to distribute updated education materials, only recently
    sharing photos showing what the rashes look like on fair skin,
    said David Harvey, executive director of the National Coalition
    of STD Directors.

    �One of the things that worries me right now is that we are
    seeing cases pop up in many countries, and we are also seeing
    numbers being reported in places that are much more aggressive
    in their surveillance than what we�ve seen here,� said Jennifer
    Nuzzo, an epidemiologist at Brown University�s School of Public
    Health.

    While monkeypox has been spreading mostly among men who have sex
    with men, the disease is not specific to any one group. �If a
    woman doesn�t have a particular known risk factor, and some
    woman shows up in urgent care, what�s the likelihood that she is
    going to get found?� Nuzzo said.

    In most cases, monkeypox symptoms disappear on their own within
    a few weeks. But for pregnant women, children and people with
    weak immune systems, the disease can lead to medical
    complications, including death, according to the WHO.

    Two federal officials involved in the monkeypox response said
    there are �significantly� more cases across the United States
    that are being missed because testing for monkeypox had not been
    expanded beyond the network of public health laboratories.

    �If we don�t move aggressively now, monkeypox is going to be
    that much harder to eradicate later � or it could even become
    endemic� in the United States, said one of the administration
    officials, who is among more than two dozen across the
    Department of Health and Human Services and the White House
    tasked with combating the outbreak and who spoke on the
    condition of anonymity because they are not authorized to speak
    to the press. Many of the same teams have been working on the
    coronavirus response.

    On Wednesday, administration officials said they were
    authorizing five major commercial laboratories to test for
    monkeypox starting in early July, a dramatic expansion of
    capacity. That could allow labs to conduct tens of thousands of
    more tests a week. Health-care providers will be able to send
    specimens directly to the commercial labs for testing without
    having to first consult with state health officials to determine
    whether testing criteria are met. Activists say the move was
    overdue.

    About 10 monkeypox tests per day were being performed nationwide
    in early June, even as other countries such as Britain were
    performing far more, a senior administration official said
    Wednesday. While laboratory testing ramped up last week, only
    about 700 total tests had been conducted as of June 17, the
    official said.

    Before the CDC made its test widely available to commercial
    labs, the agency needed to update testing protocols, establish
    agreements with the five labs and ensure personnel had personal
    protective equipment and vaccinations to protect against
    infection, according to a senior public health official who
    spoke under Biden administration ground rules that they not be
    named.

    One man who sought testing on June 13 in New York City for
    potential monkeypox symptoms � flu-like illness and swollen
    lymph nodes � was initially advised by a physician that he did
    not have the disease and did not need a test, said Joseph
    Osmundson, a virologist at New York University, who spent
    several days trying to help the individual obtain a test. The
    man had recently returned to New York from Portugal, where he
    said he had casual sex with other men. Health officials have
    advised clinicians to look out for travel-associated cases from
    Europe, and in situations in which men have had sex with men.

    But the man told The Post his efforts to obtain a test were
    repeatedly rebuffed � even after he was found to have �abnormal
    HPV-like lesions� that weren�t readily visible.

    �The pain has been like someone stabbing me from inside � I
    couldn�t sit, I couldn�t sleep,� said the man, who spoke on the
    condition of anonymity to protect his privacy. He said he went
    to four different providers, including a major New York City
    hospital, before an urgent care clinic collected a specimen on
    Monday. He said he finally received his results on Thursday
    afternoon, 10 days after he first sought testing. The results:
    positive.

    Osmundson said he was aware of a dozen similar cases in which
    people with possible monkeypox symptoms were being rebuffed.

    �The CDC is very narrowly defining criteria for testing, and the
    [New York] Department of Health is not going outside those
    criteria. So if you don�t check off on every single one of the
    boxes, based on CDC, you don�t get access to testing,� Osmundson
    said.

    Michael Lanza, a spokesman for the New York City Department of
    Health and Mental Hygiene, confirmed that providers must contact
    the agency to evaluate the case and determine whether testing is
    necessary. He said officials have not denied testing requests
    except in cases with no rash or no known risk factors.

    James Krellenstein, co-founder of PrEP4ALL, an HIV-care
    nonprofit that has pressed state and federal officials to expand
    testing, said that �no one can confidently say if the outbreak
    is under control or not.�

    �I�m extremely, extremely frustrated,� Krellenstein said. �It�s
    as if what happened in covid in February of 2020 never happened.
    This is not the first time, and to see CDC, HHS [and other
    officials] make the same errors over again is inexplicable,
    considering how large the cost was in 2020.�

    Public health experts also have criticized U.S. officials for
    not proactively vaccinating high-risk individuals against the
    virus, even as other nations have moved more aggressively to do
    so. Health officials in Britain announced a strategy Tuesday to
    offer vaccine to some gay and bisexual men at higher risk of
    exposure, and New York City officials on Thursday opened a
    vaccine clinic to those who may have been recently exposed.
    While U.S. officials have stockpiled two vaccines that are
    effective against monkeypox, there is a limited supply of the
    vaccine that is specifically authorized to prevent monkeypox,
    Jynneos.

    U.S. officials �need to have very serious planning
    conversations� about proactively vaccinating people at high risk
    for disease, said Janet Hamilton, executive director of the
    Council of State and Territorial Epidemiologists. She said
    individuals who should be prioritized include men who have sex
    with men, sex workers, lab personnel conducting monkeypox
    testing, and health-care workers expected to provide direct care
    for monkeypox patients.

    Of the two vaccines that are effective against monkeypox,
    Jynneos is in high global demand. The other vaccine, ACAM2000,
    is older and was approved to prevent smallpox. While it is
    effective against monkeypox, it can cause serious side effects
    and cannot be used for people with severely weakened immune
    systems or eczema, according to the CDC.

    Senior public health officials said Wednesday they are
    considering potential strategies for proactive vaccination.
    Current CDC recommendations call for vaccinating those at high
    risk after an exposure.

    Inger Damon, the CDC�s top orthopoxvirus expert, said at a
    briefing with reporters that federal officials have yet to
    receive information from state and local health departments on
    the number of Americans vaccinated against monkeypox.

    Krellenstein, who joined a call with senior administration
    officials on Tuesday to discuss the U.S. monkeypox strategy,
    said the administration could not answer questions about vaccine
    uptake.

    �That�s very concerning, because we do need to be making sure
    that this vaccine is going into arms,� Krellenstein said, adding
    that the lack of clarity echoed the CDC�s data problems from the
    coronavirus response.

    Officials say they also are worried about possible supply chain
    bottlenecks with the vaccine, a problem that emerged during the
    coronavirus pandemic as countries competed for resources to
    fight the virus, and hard-hit nations such as India moved to ban
    exports of coronavirus vaccines.

    Jynneos is produced by Bavarian Nordic in Denmark � and is the
    only vaccine approved by the Food and Drug Administration to
    prevent monkeypox. Some pandemic experts have warned that if the
    outbreak worsens, European officials could institute an export
    ban on Jynneos and limit shipments abroad.

    The United States currently has more than 65,000 doses of
    Jynneos, a two-shot vaccine, immediately available in its
    Strategic National Stockpile, officials said. The federal
    government has also requested that 300,000 additional government-
    owned doses be soon shipped to the United States, and has
    ordered another 500,000 doses to be delivered later this year.

    Public health experts and activists are clamoring for more-
    proactive vaccinations in high-risk communities, warning that
    the outbreak could be amplified as the gay community celebrates
    Pride Month and if clinicians miss opportunities to diagnose
    probable cases of monkeypox.

    �I had four close contacts that likely could have been avoided
    if I�d gotten my early diagnosis,� said the New York City man
    who was forced to visit four providers to get tested. He said he
    decided on his own to isolate when his symptoms worsened,
    because he worried about the virus spreading, undetected,
    through the gay community. �Hopefully we can prevent that with
    the vaccine,� he said.

    Frances Stead Sellers contributed to this report.

    Let the fags die. They don't learn, will not learn, refuse to
    learn.

    https://www.washingtonpost.com/health/2022/06/23/monkeypox- response-biden-administration/

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)